Antiepileptic Drug Formulation and Treatment in the Elderly: Biopharmaceutical Considerations

International Review of Neurobiology

Volumn 81, Issue , 2007, Pages 299-311

  Gidal, Barry E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

AGED; CHEMISTRY; EPILEPSY; GASTROINTESTINAL TRACT; HUMAN; PATHOPHYSIOLOGY; PHARMACEUTICS; REVIEW;

AGED; ANTICONVULSANTS; BIOPHARMACEUTICS; CHEMISTRY, PHARMACEUTICAL; EPILEPSY; GASTROINTESTINAL TRACT; HUMANS;

EID: 34047228580     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(06)81020-2     Document Type: Review

References (48)

1. Abruzzo C.W., Macasieb T., Weinfeld R., Rider J.A., and Kaplan S.A. Changes in the oral absorption characteristics in man of dipotassium clorazepate at normal and elevated gastric pH. J. Pharmacokinet. Biopharm. 5 (1977) 377-390
2. Altomare D.F., Portincasa P., Rinaldi M., Di Ciaula A., Martinelli E., Amoruso A., Palasciano G., and Memeo V. Slow-transit constipation: Solitary symptom of a systemic gastrointestinal disease. Dis. Colon Rectum 42 (1999) 231-240
3. Amidon G.L., Lennernas H., Shah V.P., and Crison J.R. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12 (1995) 413-420
4. Beydoun A., Uthman B.M., and Sackellares J.C. Gabapentin: Pharmacokinetics, efficacy, and safety. Clin. Neuropharmacol. 18 (1995) 469-481
5. Blechman M.B., and Gelb A.M. Aging and gastrointestinal physiology. Clin. Geriatr. Med. 15 (1999) 429-438
6. Boyd R.A., Turck D., Abel R.B., Sedman A.J., and Bockbrader H.N. Effects of age and gender on single-dose pharmacokinetics of gabapentin. Epilepsia 40 (1999) 474-479
7. Brooks M.A., Hackman M.R., Weinfeld R.E., and Macasieb T. Determination of clorazepate and its major metabolites in blood and urine by electron capture gas-liquid chromatography. J. Chromatogr. 135 (1977) 123-131
8. Burton P.S., Goodwin J.T., Vidmar T.J., and Amore B.M. Predicting drug absorption: How nature made it a difficult problem. J. Pharmacol. Exp. Ther. 303 (2002) 889-895
9. Camenisch G., Alsenz J., van de Waterbeemd H., and Folkers G. Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. 6 (1998) 317-324
10. Carlson J.A., Mann H.J., and Canafax D.M. Effect of pH on disintegration and dissolution of ketoconazole tablets. Am. J. Hosp. Pharm. 40 (1983) 1334-1336
11. Cato III A., Pollack G.M., and Brouwer K.L. Age-dependent intestinal absorption of valproic acid in the rat. Pharm. Res. 12 (1995) 284-290
12. Christensen F.N., Davis S.S., Hardy J.G., Taylor M.J., Whalley D.R., and Wilson C.G. The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations. J. Pharm. Pharmacol. 37 (1985) 91-95
13. Clarkston W.K., Pantano M.M., Morley J.E., Horowitz M., Littlefield J.M., and Burton F.R. Evidence for the anorexia of aging: Gastrointestinal transit and hunger in healthy elderly vs. young adults. Am. J. Physiol. 272 (1997) R243-R248
14. Dharmarajan T.S., Pitchumoni C.S., and Kokkat A.J. The aging gut. Pract. Gastroenterol. 25 (2001) 15-27
15. Evans M.A., Broe G.A., Triggs E.J., Cheung M., Creasey H., and Paull P.D. Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient. Neurology 31 (1981) 1288-1294
16. Fanning A.S., Mitic L.L., and Anderson J.M. Transmembrane proteins in the tight junction barrier. J. Am. Soc. Nephrol. 10 (1999) 1337-1345
17. Firth M., and Prather C.M. Gastrointestinal motility problems in the elderly patient. Gastroenterology 122 (2002) 1688-1700
18. Gidal B.E. Drug absorption in the elderly: Biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res. 68 Suppl. 1 (2006) S65-S69
19. Gidal B.E., Radulovic L.L., Kruger S., Rutecki P., Pitterle M., and Bockbrader H.N. Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability. Epilepsy Res. 40 (2000) 123-127
20. Gilron I., and Flatters S.J. Gabapentin and pregabalin for the treatment of neuropathic pain: A review of laboratory and clinical evidence. Pain Res. Manag. 11 Suppl. A (2006) 16A-29A
21. Hurwitz A., Ruhl C.E., Kimler B.F., Topp E.M., and Mayo M.S. Gastric function in the elderly: Effects on absorption of ketoconazole. J. Clin. Pharmacol. 43 (2003) 996-1002
22. Kapadia C.R. Vitamin B12 in health and disease. Part I. Inherited disorders of function, absorption, and transport. Gastroenterologist 3 (1995) 329-344
23. Kong W., Engel K., and Wang J. Mammalian nucleoside transporters. Curr. Drug Metab. 5 (2004) 63-84
24. Kwan P., and Brodie M.J. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia 46 (2005) 224-235
25. Larhed A.W., Artursson P., and Bjork E. The influence of intestinal mucus components on the diffusion of drugs. Pharm. Res. 15 (1998) 66-71
26. Lash A., and Saleem A. Iron metabolism and its regulation. A review. Ann. Clin. Lab. Sci. 25 (1995) 20-30
27. Martinez M.N., and Amidon G.L. A mechanistic approach to understanding the factors affecting drug absorption: A review of fundamentals. J. Clin. Pharmacol. 42 (2002) 620-643
28. McLean A.J., and Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 56 (2004) 163-184
29. Moran T.H., Wirth J.B., Schwartz G.J., and McHugh P.R. Interactions between gastric volume and duodenal nutrients in the control of liquid gastric emptying. Am. J. Physiol. 276 (1999) R997-R1002
30. Morris J.G. A review of some aspects of the pharmacology of levodopa. Clin. Exp. Neurol. 15 (1978) 24-50
31. Mullin J.M., Valenzano M.C., Verrecchio J.J., and Kothari R. Age- and diet-related increase in transepithelial colon permeability of Fischer 344 rats. Dig. Dis. Sci. 47 (2002) 2262-2270
32. Nordin B.E., Need A.G., Morris H.A., O'Loughlin P.D., and Horowitz M. Effect of age on calcium absorption in postmenopausal women. Am. J. Clin. Nutr. 80 (2004) 998-1002
33. Ochs H.R., Greenblatt D.J., Allen M.D., Harmatz J.S., Shader R.I., and Bodem G. Effect of age and Billroth gastrectomy on absorption of desmethyldiazepam from clorazepate. Clin. Pharmacol. Ther. 26 (1979) 449-456
34. Orr W.C., and Chen C.L. Aging and neural control of the GI tract: IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am. J. Physiol. Gastrointest. Liver Physiol. 283 (2002) G1226-G1231
35. Palm K., Luthman K., Ungell A.L., Strandlund G., and Artursson P. Correlation of drug absorption with molecular surface properties. J. Pharm. Sci. 85 (1996) 32-39
36. Robertson D.R., Wood N.D., Everest H., Monks K., Waller D.G., Renwick A.G., and George C.F. The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. Br. J. Clin. Pharmacol. 28 (1989) 61-69
37. Russell T.L., Berardi R.R., Barnett J.L., Dermentzoglou L.C., Jarvenpaa K.M., Schmaltz S.P., and Dressman J.B. Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women. Pharm. Res. 10 (1993) 187-196
38. Sakaeda T., Nakamura T., and Okumura K. MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol. Pharm. Bull. 25 (2002) 1391-1400
39. Saltzman J.R., Kowdley K.V., Perrone G., and Russell R.M. Changes in small-intestine permeability with aging. J. Am. Geriatr. Soc. 43 (1995) 160-164
40. Schwartz J.B. Erythromycin breath test results in elderly, very elderly, and frail elderly persons. Clin. Pharmacol. Ther. 79 (2006) 440-448
41. Shankle W.R., Landing B.H., Ang S.M., Chui H., Villarreal-Engelhardt G., and Zarow C. Studies of the enteric nervous system in Alzheimer disease and other dementias of the elderly: Enteric neurons in Alzheimer disease. Mod. Pathol. 6 (1993) 10-14
42. Siest G., Jeannesson E., Berrahmoune H., Maumus S., Marteau J.B., Mohr S., and Visvikis S. Pharmacogenomics and drug response in cardiovascular disorders. Pharmacogenomics 5 (2004) 779-802
43. Toothaker R.D., and Welling P.G. The effect of food on drug bioavailability. Annu. Rev. Pharmacol. Toxicol. 20 (1980) 173-179
44. Tsuji A. Small molecular drug transfer across the blood-brain barrier via carrier-mediated transport systems. NeuroRx 2 (2005) 54-62
45. Van Aubel R.A., Masereeuw R., and Russel F.G. Molecular pharmacology of renal organic anion transporters. Am. J. Physiol. Renal Physiol. 279 (2000) F216-F232
46. 15N-labelled drug to healthy volunteers. Br. J. Clin. Pharmacol. 32 (1991) 573-579
47. Wilkinson G.R. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv. Drug Deliv. Rev. 27 (1997) 129-159
48. Yamaoka Y., Roberts R.D., and Stella V.J. Low-melting phenytoin prodrugs as alternative oral delivery modes for phenytoin: A model for other high-melting sparingly water-soluble drugs. J. Pharm. Sci. 72 (1983) 400-405